What is the rare blood cancer myelofibrosis? And how do you treat it? In this video, top myelofibrosis experts discuss the latest treatment options for myelofibrosis, how to deal with myelofibrosis symptoms, and how factors like age, mutation status, treatment history, and personal preferences impact your treatment.

Patient advocate Ruth Fein is joined by Dr. Raajit Rampal with Memorial Sloan Kettering Cancer Center and Dr. Gaby Hobbs with Mass General Cancer Center.

Key topics covered:
⇢ Exciting phase 3 trial results for navitoclax (TRANSFORM-1) and pelabresib (MANIFEST-2)
⇢ Latest data on fedratinib (FREEDOM trial) and selinexor (XPORT trial)
⇢ New treatment options to help manage anemia in myelofibrosis, including momelotinib and other pipeline drugs

Full article here ⇢ [ Ссылка ]

#cancerstories #thepatientstory #myelofibrosis #rarecancer #MPN #cancerresearch #bloodcancer #cancertreatment #myeloproliferativeneoplasms #myeloproliferativeneoplasm #raredisease #bloodcancer #hematology #diagnosis #treatment

Myelofibrosis:
Myelofibrosis is an uncommon type of bone marrow cancer that disrupts your body's normal production of blood cells. It can cause severe scarring in your bone marrow, leading to severe anemia that can cause weakness and fatigue. Myelofibrosis often causes an enlarged spleen.

Myelofibrosis is considered to be a chronic leukemia — a cancer that affects the blood-forming tissues in the body. Myelofibrosis belongs to a group of diseases called myeloproliferative disorders.

The Patient Story:
The Patient Story is led by a dedicated team of medical, editorial, and video experts, committed
to authentically portraying the cancer patient experience. Sharing your story holds
transformative power, culturally and personally. We handle each narrative with utmost care,
compassion, and scientific rigor.

Our editorial process adheres to the highest journalistic standards, ensuring medically
researched, vetted, and fact-checked content. Backed by experienced medical professionals,
we offer insights into the latest medical advancements.
Beyond patient narratives, we provide comprehensive coverage of cancer news and medical
resources. From symptoms to clinical trials, insurance, finances, and support groups, we offer
guidance in a humanized manner.

Join Our Community:
Sign up for our FREE website: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
Twitter: [ Ссылка ]
Tik Tok: [ Ссылка ]

The interview has only been edited for clarity.

* Thank you to GSK and Karyopharm for their support of our patient education program!
The Patient Story retains full editorial control over all content.

свернуть